Literature DB >> 4005349

Relaxin activity in the pregnant cat.

D R Stewart, G H Stabenfeldt.   

Abstract

Plasma relaxin activity was measured by radioimmunoassay (RIA) in the domestic cat utilizing two different antisera developed against highly purified porcine relaxin. One was the 5858 antiserum from our laboratory and the other was the R6 antiserum of Dr. Bernard Steinetz. Relaxin activity could not be detected during the estrous cycle or during pseudopregnancy. Relaxin immunoactivity during early gestation was not detected by either antiserum. Plasma relaxin immunoactivity was first detected by both antisera on about Day 25 of gestation. Relaxin concentrations then increased rapidly, with a plateau reached between Days 30 and 35 that was maintained until 10-15 days prepartum. Relaxin concentrations then declined gradually until parturition. No prepartum increase was observed. Relaxin concentrations were undetectable within 24 h of delivery. Although amounts of immunoactivity measured with the R6 antiserum were consistently higher than measurements with the 5858 antiserum, the patterns of secretions observed were similar for both antisera.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4005349     DOI: 10.1095/biolreprod32.4.848

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  3 in total

1.  Relaxin as a hormonal aid to evaluate pregnancy and pregnancy loss in bottlenose dolphins (Tursiops truncatus).

Authors:  Don R Bergfelt; Jason L Blum; Bernard G Steinetz; Karen J Steinman; Justin K O'Brien; Todd R Robeck
Journal:  Gen Comp Endocrinol       Date:  2015-12-24       Impact factor: 2.822

Review 2.  Feline breeding and pregnancy management: What is normal and when to intervene.

Authors:  Bodil Ström Holst
Journal:  J Feline Med Surg       Date:  2022-03       Impact factor: 1.971

Review 3.  Canine and feline pregnancy loss due to viral and non-infectious causes: a review.

Authors:  J Verstegen; G Dhaliwal; K Verstegen-Onclin
Journal:  Theriogenology       Date:  2008-06-10       Impact factor: 2.740

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.